Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
13F holders, Q1 2025 (March 31)16holders −4
1new positions
5sold out
$8.46avg. 13F price*
At the end of Q1 2025, 16 institutions reported holding Biomarin Pharmaceutical (bmrn 1.25 05/15/27) in their 13F filings, down 4 from Q4 2024. 1 opened new positions and 5 sold out. The largest holders were Loomis Sayles & Co. L P ($69.8M), Sonora Investment Management Group, LLC ($3.9M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.7M).
- Company
- Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
- CUSIP
- 09061GAK7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $40K |
| Exits | 5 | $16.5M |
All 13F filers, Q4 2024 → Q1 2025: 46,000 shares bought and 18,496,827 shares sold, net −18,450,827 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Loomis Sayles & Co. L P | 0.10% | Reduce -32.1% | 987,865 | $69.8M |
| Sonora Investment Management Group, LLC | 0.31% | Reduce -2.9% | 4,080,000 | $3.9M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Reduce 0.0% | 2,899,999 | $2.7M |
| Sei Investments Co. | 0.00% | No change | 524,000 | $493K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $283K |
| Oppenheimer Asset Management Inc. | 0.00% | Add +1.1% | 180,000 | $169K |
| Stephens Inc. | 0.00% | Add +2.0% | 52,000 | $49K |
| B. Riley Wealth Advisors, Inc. | 0.00% | New | 43,000 | $40K |
| Mariner, LLC | 0.00% | No change | 42,000 | $39K |
| Choreo, LLC | 0.00% | Reduce -8.0% | 23,000 | $22K |
| Comerica Bank | 0.00% | No change | 15,000 | $14K |
| DAVENPORT & Co LLC | 0.00% | No change | 10,000 | $9K |
| Cetera Investment Advisers | 0.00% | Reduce -94.0% | 10,000 | $9K |
| MAI Capital Management | 0.00% | No change | 2,000 | $2K |
| Oddo BHF Asset Management Sas | 0.00% | No change | 425 | $403 |
| Intellectus Partners, LLC | 0.00% | Reduce -10.8% | 289 | $273 |
"% of holder's portfolio" is BIOMARIN PHARMACEUTICAL (BMRN 1.25 05/15/27)'s weight in each manager's 13F, not the share of Biomarin Pharmaceutical (bmrn 1.25 05/15/27) the manager owns.